“Natural Regulators”: NK Cells as Modulators of T Cell Immunity

por Schuster, Iona S., Coudert, Jerome D., Andoniou, Christopher E., Degli-Esposti, Mariapia A.
Publicado 2016

Ly49C-Dependent Control of MCMV Infection by NK Cells Is Cis-Regulated by MHC Class I Molecules

por Forbes, Catherine A., Scalzo, Anthony A., Degli-Esposti, Mariapia A., Coudert, Jerome D.
Publicado 2014

A novel checkpoint in the Bcl-2–regulated apoptotic pathway revealed by murine cytomegalovirus infection of dendritic cells

por Andoniou, Christopher E., Andrews, Daniel M., Manzur, Mitali, Ricciardi-Castagnoli, Paola, Degli-Esposti, Mariapia A.
Publicado 2004

Boosting Live Malaria Vaccine with Cytomegalovirus Vector Can Prolong Immunity through Innate and Adaptive Mechanisms

por Gbedande, Komi, Ibitokou, Samad A., Ong, Monique L., Degli-Esposti, Mariapia A., Brown, Michael G., Stephens, Robin
Publicado 2023

M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection

por Cretney, Erika, Degli-Esposti, Mariapia A., Densley, Eloise H., Farrell, Helen E., Davis-Poynter, Nick J., Smyth, Mark J.
Publicado 1999

MCMV-mediated Inhibition of the Pro-apoptotic Bak Protein Is Required for Optimal In Vivo Replication

por Fleming, Peter, Kvansakul, Marc, Voigt, Valentina, Kile, Benjamin T., Kluck, Ruth M., Huang, David C. S., Degli-Esposti, Mariapia A., Andoniou, Christopher E.
Publicado 2013

Cytomegalovirus establishes a latent reservoir and triggers long-lasting inflammation in the eye

por Voigt, Valentina, Andoniou, Christopher E., Schuster, Iona S., Oszmiana, Anna, Ong, Monique L., Fleming, Peter, Forrester, John V., Degli-Esposti, Mariapia A.
Publicado 2018

A Contribution of Mouse Dendritic Cell–Derived IL-2 for NK Cell Activation

por Granucci, Francesca, Zanoni, Ivan, Pavelka, Norman, van Dommelen, Serani L.H., Andoniou, Christopher E., Belardelli, Filippo, Degli Esposti, Mariapia A., Ricciardi-Castagnoli, Paola
Publicado 2004

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

por Degli-Esposti, Mariapia A., Smolak, Pamela J., Walczak, Henning, Waugh, Jennifer, Huang, Chang-Pin, DuBose, Robert F., Goodwin, Raymond G., Smith, Craig A.
Publicado 1997

The Murine Natural Cytotoxic Receptor NKp46/NCR1 Controls TRAIL Protein Expression in NK Cells and ILC1s

por Sheppard, Sam, Schuster, Iona S., Andoniou, Christopher E., Cocita, Clement, Adejumo, Thomas, Kung, Sam K.P., Sun, Joseph C., Degli-Esposti, Mariapia A., Guerra, Nadia
Publicado 2018

Ocular antigen does not cause disease unless presented in the context of inflammation

por Voigt, Valentina, Wikstrom, Matthew E., Kezic, Jelena M., Schuster, Iona S., Fleming, Peter, Makinen, Kimmo, Daley, Stephen R., Andoniou, Christopher E., Degli-Esposti, Mariapia A., Forrester, John V.
Publicado 2017

Murine cytomegalovirus infection exacerbates complex IV deficiency in a model of mitochondrial disease

por Ferreira, Nicola, Andoniou, Christopher E., Perks, Kara L., Ermer, Judith A., Rudler, Danielle L., Rossetti, Giulia, Periyakaruppiah, Ambika, Wong, Jamie K. Y., Rackham, Oliver, Noakes, Peter G., Degli-Esposti, Mariapia A., Filipovska, Aleksandra
Publicado 2020

CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation

por Tze, Lina E., Horikawa, Keisuke, Domaschenz, Heather, Howard, Debbie R., Roots, Carla M., Rigby, Robert J., Way, David A., Ohmura-Hoshino, Mari, Ishido, Satoshi, Andoniou, Christopher E., Degli-Esposti, Mariapia A., Goodnow, Christopher C.
Publicado 2011

Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration

por Constable, Ian J., Pierce, Cora M., Lai, Chooi-May, Magno, Aaron L., Degli-Esposti, Mariapia A., French, Martyn A., McAllister, Ian L., Butler, Steve, Barone, Samuel B., Schwartz, Steven D., Blumenkranz, Mark S., Rakoczy, Elizabeth P.
Publicado 2016

Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor Growth

por van der Most, Robbert G., Currie, Andrew J., Cleaver, Amanda L., Salmons, Joanne, Nowak, Anna K., Mahendran, Sathish, Larma, Irma, Prosser, Amy, Robinson, Bruce W. S., Smyth, Mark J., Scalzo, Anthony A., Degli-Esposti, Mariapia A., Lake, Richard A.
Publicado 2009

Innate immunity defines the capacity of antiviral T cells to limit persistent infection

por Andrews, Daniel M., Estcourt, Marie J., Andoniou, Christopher E., Wikstrom, Matthew E., Khong, Andrea, Voigt, Valentina, Fleming, Peter, Tabarias, Hyacinth, Hill, Geoffrey R., van der Most, Robbert G., Scalzo, Anthony A., Smyth, Mark J., Degli-Esposti, Mariapia A.
Publicado 2010

A Natural Genetic Variant of Granzyme B Confers Lethality to a Common Viral Infection

por Andoniou, Christopher E., Sutton, Vivien R., Wikstrom, Matthew E., Fleming, Peter, Thia, Kevin Y. T., Matthews, Antony Y., Kaiserman, Dion, Schuster, Iona S., Coudert, Jerome D., Eldi, Preethi, Chaudhri, Geeta, Karupiah, Gunasegaran, Bird, Phillip I., Trapani, Joseph A., Degli-Esposti, Mariapia A.
Publicado 2014